What is proper cancer care in the era of managed care?
暂无分享,去创建一个
[1] M. J. Hoeksema,et al. Cancer mortality rates fall: a turning point for the nation. , 1996, Journal of the National Cancer Institute.
[2] P. Kantoff,et al. NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network. , 1996, Oncology.
[3] J. Moul,et al. Age-specific reference ranges for serum prostate-specific antigen in black men. , 1996, The New England journal of medicine.
[4] J. Moul,et al. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. , 1996, The Journal of urology.
[5] J. Oesterling,et al. Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association. , 1995, The Journal of urology.
[6] S. Woolf. Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. , 1995, The New England journal of medicine.
[7] W. Catalona,et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. , 1995, JAMA.
[8] R. Abrams,et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. , 1995, Urology.
[9] R. Morton,et al. Racial differences in adenocarcinoma of the prostate in North American men. , 1994, Urology.
[10] C. Bangma,et al. Age-specific reference ranges for prostate-specific antigen. , 1994, JAMA.
[11] W. Catalona,et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.
[12] Boris Rubinsky,et al. Transrectal ultrasound‐guided percutaneous radical cryosurgical ablation of the prostate , 1993, Cancer.
[13] G. P. Monaco. The Partnership of Empowerment , 1992 .
[14] E. Metter,et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.
[15] G. D'angio. Cure Is Not Enough: Late Consequences Associated with Radiation Treatment , 1988, Journal of the Association of Pediatric Oncology Nurses.
[16] A. Meadows. The Concept of Care for Life , 1988, Journal of the Association of Pediatric Oncology Nurses.
[17] S. Sharfstein. From Advocacy to Allocation: The Evolving American Health Care System , 1987 .
[18] F. Mullan. The Cancer Consort , 1987 .
[19] Wittes Re. Paying for patient care in treatment research--who is responsible? , 1987 .
[20] P. Wingo,et al. Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.
[21] Curtis Mettlin,et al. Defining and updating the american cancer society guidelines for the cancer‐related checkup: Prostate and endometrial cancers , 1993, CA: a cancer journal for clinicians.
[22] G. P. Monaco. Moving ahead in cancer research: who pays for patient supportive care for participation in experimental/investigational trials? , 1991, Cancer investigation.
[23] R. Wittes. Paying for patient care in treatment research--who is responsible? , 1987, Cancer treatment reports.